Please login to the form below

Not currently logged in
Email:
Password:

Roche and Evotec form biomarker alliance

Roche and Evotec are to collaborate on protein-activity based biomarkers for Roche's oncology drugs under development

Roche and Evotec, a drug discovery company specialising in development partnerships, are to collaborate on protein-activity based biomarkers for Roche's oncology drugs under development.

Evotec will employ its PhosphoScout platform to discover protein-phosphorylation's that predict favourable dosage and efficacy of targeted cancer drugs in patients. Roche will be responsible for conducting clinical trials, as well as assessing the development of companion diagnostics for patient stratification.

Mike Burgess, global head of oncology at Roche Pharma Research and Exploratory Development, said: "We are very pleased to collaborate with Evotec and benefit from the PhosphoScout technology to identify appropriate pharmacodynamics and patient stratification biomarkers. They are core to the development of targeted therapeutics for cancer therapy."

Under the initial three-year term Roche and Evotec will conduct multiple biomarker programmes for therapeutic antibodies or small molecule inhibitors.

27th June 2011

Share

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Sustainability
Environment: where does the pharmaceutical industry stand?
...
The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...